Literature DB >> 29553521

Absolute Quantification of Plasma MicroRNA Levels in Cynomolgus Monkeys, Using Quantitative Real-time Reverse Transcription PCR.

Takuma Iguchi1, Noriyo Niino2, Satoshi Tamai2, Ken Sakurai2, Kazuhiko Mori2.   

Abstract

RT-qPCR is one of the most common methods to assess individual target miRNAs. MiRNAs levels are generally measured relative to a reference sample. This approach is appropriate for examining physiological changes in target gene expression levels. However, absolute quantification using better statistical analysis is preferable for a comprehensive assessment of gene expression levels. Absolute quantification is still not in common use. This report describes a protocol for measuring the absolute levels of plasma miRNA, using RT-qPCR with or without pre-amplification. A fixed volume (200 µL) of EDTA-plasma was prepared from the blood collected from the femoral vein of conscious cynomolgus monkeys (n = 50). Total RNA was extracted using commercially available system. Plasma miRNAs were quantified by probe-based RT-qPCR assays which contains miRNA-specific forward/reverse PCR primer and probe. Standard curves for absolute quantification were generated using commercially available synthetic RNA oligonucleotides. A synthetic cel-miR-238 was used as an external control for normalization and quality assessment. The miRNAs that showed quantification cycle (Cq) values above 35 were pre-amplified prior to the qPCR step. Among the 8 miRNAs examined, miR-122, miR-133a, and miR-192 were detectable without pre-amplification, whereas miR-1, miR-206, and miR-499a required pre-amplification because of their low expression levels. MiR-208a and miR-208b were not detectable even after pre-amplification. Sample processing efficiency was evaluated by the Cq values of the spiked cel-miR-238. In this assay method, technical variation was estimated to be less than 3-fold and the lower limit of quantification (LLOQ) was 102 copy/µL, for most of the examined miRNAs. This protocol provides a better estimate of the quantity of plasma miRNAs, and allows quality assessment of corresponding data from different studies. Considering the low number of miRNAs in body fluids, pre-amplification is useful to enhance detection of poorly expressed miRNAs.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29553521      PMCID: PMC5912405          DOI: 10.3791/56850

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

Review 1.  Serum microRNAs as a novel class of biomarkers: a comprehensive review of the literature.

Authors:  Nathalie Schöler; Christian Langer; Hartmut Döhner; Christian Buske; Florian Kuchenbauer
Journal:  Exp Hematol       Date:  2010-10-25       Impact factor: 3.084

2.  Avoiding heparin inhibition in circulating MicroRNAs amplification.

Authors:  Sufang Li; Hong Chen; Junxian Song; Chongyou Lee; Qiang Geng
Journal:  Int J Cardiol       Date:  2016-01-09       Impact factor: 4.164

3.  Quantification of circulating miRNAs in plasma: effect of preanalytical and analytical parameters on their isolation and stability.

Authors:  Ioanna S Sourvinou; Athina Markou; Evi S Lianidou
Journal:  J Mol Diagn       Date:  2013-08-27       Impact factor: 5.568

4.  How to do successful gene expression analysis using real-time PCR.

Authors:  Stefaan Derveaux; Jo Vandesompele; Jan Hellemans
Journal:  Methods       Date:  2009-12-05       Impact factor: 3.608

5.  A set of external reference controls/probes that enable quality assurance between different microarray platforms.

Authors:  Hideo Akiyama; Yoji Ueda; Hitoshi Nobumasa; Hiroyuki Ooshima; Yohei Ishizawa; Koji Kitahiro; Isao Miyagawa; Kazufumi Watanabe; Takazumi Nakamura; Ritsuka Tanaka; Nobuko Yamamoto; Hiroki Nakae; Mitsuo Kawase; Nobuhiro Gemma; Yuji Sekiguchi; Wataru Fujibuchi; Ryo Matoba
Journal:  Anal Biochem       Date:  2014-12-04       Impact factor: 3.365

6.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR).

Authors:  Evan M Kroh; Rachael K Parkin; Patrick S Mitchell; Muneesh Tewari
Journal:  Methods       Date:  2010-02-08       Impact factor: 3.608

Review 7.  Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury.

Authors:  Janika Viereck; Thomas Thum
Journal:  Circ Res       Date:  2017-01-20       Impact factor: 17.367

8.  Quantification of circulating miRNAs by droplet digital PCR: comparison of EvaGreen- and TaqMan-based chemistries.

Authors:  Elena Miotto; Elena Saccenti; Laura Lupini; Elisa Callegari; Massimo Negrini; Manuela Ferracin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

9.  SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses.

Authors:  Francesca Malentacchi; Mario Pazzagli; Lisa Simi; Claudio Orlando; Ralf Wyrich; Kalle Günther; Paolo Verderio; Sara Pizzamiglio; Chiara Maura Ciniselli; Hui Zhang; Vlasta Korenková; Lynne Rainen; Tzachi Bar; Mikael Kubista; Stefania Gelmini
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 10.  Methodological challenges in utilizing miRNAs as circulating biomarkers.

Authors:  Leni Moldovan; Kara E Batte; Joanne Trgovcich; Jon Wisler; Clay B Marsh; Melissa Piper
Journal:  J Cell Mol Med       Date:  2014-02-18       Impact factor: 5.310

View more
  3 in total

1.  Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation.

Authors:  Juan Wang; Jin Wen; Xiao-Xiang Chen; Guang-Liang Chen
Journal:  J Vis Exp       Date:  2018-08-23       Impact factor: 1.355

2.  Single-step RT-qPCR for detection of extracellular vesicle microRNAs in vivo: a time- and cost-effective method.

Authors:  Heedoo Lee; Xue He; Trung Le; Jonathan M Carnino; Yang Jin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-02-19       Impact factor: 5.464

Review 3.  Considerations and Suggestions for the Reliable Analysis of miRNA in Plasma Using qRT-PCR.

Authors:  Eunmi Ban; Eun Joo Song
Journal:  Genes (Basel)       Date:  2022-02-10       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.